Adjuvant treatment improves overall survival in women with high-intermediate risk early-stage endometrial cancer with lymphovascular space invasion.
Son J, Chambers LM, Carr C, Michener CM, Yao M, Beavis A, Yen TT, Stone RL, Wethington SL, Fader AN, Burkett WC, Richardson DL, Staley AS, Ahn S, Gehrig PA, Torres D, Dowdy SC, Sullivan MW, Modesitt SC, Watson C, Veade A, Ehrisman J, Havrilesky L, Secord AA, Loreen A, Griffin K, Jackson A, Viswanathan A, Ricci S.
Son J, et al. Among authors: wethington sl.
Int J Gynecol Cancer. 2020 Nov;30(11):1738-1747. doi: 10.1136/ijgc-2020-001454. Epub 2020 Aug 7.
Int J Gynecol Cancer. 2020.
PMID: 32771986